Aptabio Therapeutics (XKRX:293780) ROE % Adjusted to Book Value : -5.09% (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Aptabio Therapeutics ROE % Adjusted to Book Value?

Aptabio Therapeutics's ROE % for the quarter that ended in Mar. 2025 was -19.48%. Aptabio Therapeutics's PB Ratio for the quarter that ended in Mar. 2025 was 3.83. Aptabio Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2025 was -5.09%.

Aptabio Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Aptabio Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptabio Therapeutics ROE % Adjusted to Book Value Chart

Aptabio Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-0.68

-1.19

-4.09

-6.39

-16.09

Aptabio Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-9.74	-11.64	-16.21	-25.41	-5.09

Competitive Comparison of Aptabio Therapeutics's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Aptabio Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptabio Therapeutics's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aptabio Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Aptabio Therapeutics's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Aptabio Therapeutics ROE % Adjusted to Book Value Calculation

Aptabio Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-50.84%	/	3.16
	=	-16.09%

Aptabio Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-19.48%	/	3.83
	=	-5.09%

Aptabio Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Aptabio Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptabio Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aptabio Therapeutics Inc (XKRX:293780) » Definitions » ROE % Adjusted to Book Value

Traded in Other Exchanges

N/A

Address

13, Heungdeok 1-ro, Giheung-gu, Tower 504, Gyeonggi-do, Yongin-Si, KOR, 16954

Website

http://www.aptabio.com

Aptabio Therapeutics Inc is a South Korean pharmaceutical company involved in discovery and development of selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The product portfolio of the company include Lipofector-Q, Plusfector, Lipofector-EXT, Lipofector-2000, Lipofector-EZ and Lipofector-pMAX.

Aptabio Therapeutics Headlines

No Headlines